4-Trifluoromethoxyphenoxybenzol-4'-su lfonic acids, method for the production and use thereof in medicaments

Details for Australian Patent Application No. 2005259634 (hide)

Owner Sanofi-Aventis Deutschland GmbH

Inventors Hofmeister, Armin; Schudok, Manfred

Agent Watermark

Pub. Number AU-A-2005259634

PCT Pub. Number WO2006/002764

Priority 10 2004 031 620.1 30.06.04 DE

Filing date 15 June 2005

Wipo publication date 12 January 2006

International Classifications

C07D 217/26 (2006.01) Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems

C07D 223/16 (2006.01) Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom

C07D 493/04 (2006.01) Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system

Event Publications

25 January 2007 PCT application entered the National Phase

  PCT publication WO2006/002764 Priority application(s): WO2006/002764

19 January 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005259664-Care composition

2005259633-Substituted tetrahydroisochinolines used in the form of MMP inhibitors, method for the production and use thereof in the form of drags